Description

Clindamycin Myristate is a chemically modified ester derivative of the lincosamide antibiotic clindamycin. This modification enhances the compound's lipophilicity and stability, making it a crucial intermediate in the synthesis of advanced pharmaceutical formulations. It is primarily utilized by manufacturers in the pharmaceutical and biotechnology sectors for the development of topical and parenteral antibiotic products. The compound offers significant value in creating more effective and stable drug delivery systems.

Application

• Pharmaceutical Intermediate: Key starting material for synthesizing various clindamycin-based antibiotic formulations.
• Topical Medication Production: Used in the manufacture of gels, lotions, and creams for treating acne and bacterial skin infections.
• Injectable Formulations: Serves as a precursor for developing sterile injectable solutions with improved pharmacokinetic profiles.
• Veterinary Medicine: Employed in creating antibiotic treatments for bacterial infections in animals.
• Research & Development: Utilized in biochemical and pharmacological research to study antibiotic mechanisms and develop new derivatives.
• Controlled-Release Systems: Integral in designing advanced drug delivery systems that provide sustained release of the active ingredient.

Basic Information

Product Name	Clindamycin Myristate
CAS No.	1123211-66-4
Molecular Formula	C32H61ClN2O6S
Molecular Weight	625.36 g/mol
Synonyms	Clindamycin Tetradecanoate; Clindamycin Myristic Acid Ester; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxylic acid tetradecanoate ester; 7(S)-Chloro-7-deoxylincomycin 2-tetradecanoate; U-28508; Antibiotic U 28508
EINECS	Contact for details

Quality Control

Our Clindamycin Myristate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including identification, assay, and impurity profiling, to ensure it meets high-purity standards suitable for pharmaceutical applications. Certificates of Analysis (COA) detailing all test results are provided with every shipment to guarantee traceability and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive) and should be kept under an inert atmosphere if the container is opened frequently to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.